Stock & Company Details
Moderna Inc $MRNA
Price:
N/A
N/A
399M
$79B
52 Week High:
N/A
10 Day Average Volume:
N/A
-24.67
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
MRNA technical indicators
Latest Moderna Inc (MRNA) indicator readings as of 2026-10-09.
MRNA's 14-day RSI is 72.1, in overbought territory. At $225.00 it is trading 209.8% above its 200-day moving average of $72.63, and above its 50-day average of $138.26. Price sits near the upper Bollinger Band ($139.28 to $226.81). ADX reads 62.4, indicating a trending market.
MRNA backtested strategy results
How 4 rule-based strategies performed on Moderna Inc (MRNA) over recent history, last backtested 2026-09-06. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | -59.3% | 16% | 19 | -86.3% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | +154.5% | 38% | 26 | -45.1% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | +160.9% | 43% | 28 | -39.2% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +87.8% | 52% | 33 | -60.6% |
Overview
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Finance Bot
Ask your questions
Start by typing a question below.
